San Francisco, CA -- (SBWIRE) -- 08/23/2013 -- Pennystocksforever.com focuses on Fast Moving Stocks, have a look on today’s picks: GT Advanced Technologies Inc (NASDAQ:GTAT), Harmony Gold Mining Co. (ADR) (NYSE:HMY), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Northstar Realty Finance Corp. (NYSE:NRF)
GT Advanced Technologies Inc (NASDAQ:GTAT) opened the session at $6.24, remained amid the day range of $6.24 - $6.48, and closed the session at $6.44. The stock showed a positive performance of 4.21% in previous trading session. The stock gained a volume of 2.84 million shares and the average volume of the stock remained 4.52 million shares. GT Advanced Technologies Inc. is diversified technology company with crystal growth equipment and solutions for the global solar, light emitting diode (LED) and electronics industries. The Company operates in three segments: its polysilicon business, its photovoltaic (PV), business and its sapphire business.
For How Long GTAT will Fight for Profitability? Read This Trend Analysis report
Harmony Gold Mining Co. (ADR) (NYSE:HMY) traded with volume of 2.67 million shares in the prior session and the average volume of the stock remained 325 million shares. The 52 week range of the stock remained $3.29 - $9.81. The stock showed a positive movement of 2.09% and closed its session at $3.91. The market capitalization of the stock remained 1.70 billion. Harmony Gold Mining Company Limited (Harmony) is engaged in conducting underground and surface gold mining and related activities, including exploration, processing and smelting. During the fiscal year ended June 30, 2012 (fiscal 2012), its mining operations reported total proven and probable reserves of 52.9 million ounces (including gold equivalent ounces), primarily from South African sources.
For How Long HMY Gloss will Attract Investors? Find out via this report
Celldex Therapeutics, Inc. (NASDAQ:CLDX) exchanged 2.65 million shares and the average volume remained 1.51 million shares. The stock escalated 4.49% and closed the session at $23.26. The beta of the stock remained 2.05 and the EPS of the stock remained -0.99. The shares outstanding of the stock remained 80.99 million. Celldex Therapeutics, Inc. (Celldex), is a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases.
Will CLDX Continue To Move Higher? Find Out Here
Northstar Realty Finance Corp. (NYSE:NRF) gained volume of 2.62 million shares, while the average volume remained 4.01 million shares. The stock advanced 1.27% and finished the session Thursday at $8.77. The EPS of the stock remained -1.38. The one month of the stock was -12.48% and three month trend remained negative -12.48%.NorthStar Realty Finance Corp. is an internally managed real estate finance company. It originates, acquires and manages portfolios of commercial real estate debt, commercial real estate securities and net lease properties.
Why Should Investors Buy NRF After The Recent Gain? Just Go Here and Find Out
Here at Penny Stocks Forever we focus Fast Moving Stocks, We are different from other newsletters that focus on just hype. One of our alerts went from $.77 to a high of $25.00 in just 2 months, while these types of rallies are rare they do happen. Join our newsletter today to start receiving our free alerts!! We present facts for your evaluation in a respectable way.
PLEASE NOTE WELL: This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
PennyStocksForever.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice.
Read Full Disclaimer at: http://www.pennystocksforever.com/disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)